Brazil accounts for 83% of a Latin American vertebral fusion market that Implanet has valued at €139MM (~$152MM). Company leadership estimates that ~27,000 vertebral fusion procedures occurred in the Brazil market, during 2015.
Implanet reports completion of the first idiopathic scoliosis surgical procedure to use the JAZZ platform in Brazil.
This follows closely the ANVISA approval for JAZZ in mid-4Q15.
Brazil accounts for 83% of a Latin American vertebral fusion market that Implanet has valued at €139MM (~$152MM). Company leadership estimates that ~27,000 vertebral fusion procedures occurred in the Brazil market, during 2015.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
